spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Envirotainer and Swiss WorldCargo complete the first commercial shipment using the new Releye® RAP

Envirotainer



Stockholm, March 11, 2022: Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that the first commercial shipment using the new Releye® RAP container has been completed. The consignment was handled by Swiss WorldCargo, one of the leading carriers of intensive care pharmaceuticals.

The shipment started in Basel, Switzerland, landing at JFK in the US and comprised of three Releye® RAP units and two RAP e2 units. The shipper was a global acting Swiss pharmaceutical company, and the transportation was successful and went according to plan.

Thanks to the integrated live monitoring, the shipment was checked in every detail through the whole journey. Furthermore, with Envirotainer’s new Control Tower service, a global team of operators stood ready to respond within minutes to any critical event, if one should have occurred. The Envirotainer Control Tower service is included in all Releye® leases.

And, since the Releye® RAP is based on exactly the same platform and technology as the Releye® RLP together with the comprehensive data made available, the qualification for the pharmaceutical company customer required marginal effort and went exceptionally fast.

For more information, please visit www.envirotainer.com/releye
phone +46 18 34 73 00
email info@envirotainer.com
web www.envirotainer.com
email Head office R&D Manufacturing, Envirotainer AB, Lagga Marma, SE-741 93 Knivsta, Sweden
 
Print this page
Send to a friend
   
spacer
News and Press Releases

va-Q-tec: Global specialist for TempChain transport solutions and energy efficiency continues on successful track in the first half of 2022

Würzburg, 11 August, 2022. va-Q-tec AG (ISIN DE0006636681 / WKN 663668), a pioneer in highly efficient products and solutions in the thermal insulation (so-called super insulation) and temperature-managed supply chains (so-called TempChain logistics) area, continued on its past quarters’ profitable growth path in the first half of 2022. Revenue growth in the first half of 2022 was very gratifying overall despite the challenging macroeconomic environment, thanks to the highly sought-after product and service portfolio.
More info >>


White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement